Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 10, 2015, Pages

  Cleminson, Jemma ^a   Austin, Nicola ^b   Mcguire, William ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b Christchurch Womens Hospital   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; NYSTATIN; PLACEBO;

ANTIFUNGAL THERAPY; CHRONIC LUNG DISEASE; DRUG DOSE REGIMEN; FUNGUS ISOLATION; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INFANT MORTALITY; INFECTION PREVENTION; INFECTION RATE; LENGTH OF STAY; MINIMUM INHIBITORY CONCENTRATION; MORTALITY RISK; NECROTIZING ENTEROCOLITIS; NEWBORN MORBIDITY; NONHUMAN; OUTCOME ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; SYSTEMIC MYCOSIS; SYSTEMIC THERAPY; VERY LOW BIRTH WEIGHT; COMPLICATION; DEVELOPMENTAL DISABILITIES; INFANT, PREMATURE, DISEASES; META ANALYSIS; MORTALITY; MYCOSES; NEWBORN; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTIFUNGAL AGENTS; DEVELOPMENTAL DISABILITIES; FLUCONAZOLE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; MYCOSES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84979862658     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003850.pub5     Document Type: Review

References (85)

1. Arrieta AC, Shea K, Dhar V, Cleary JP, Kukreja S, Morris M, et al. Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: a prospective, randomized, open-label, placebo-controlled pilot study. Clinical Therapeutics 2010;32(2):265-71. [PUBMED: 20206784]
2. Aydemir C, Oguz SS, Dizdar EA, Akar M, Sarikabadayi YU, Saygan S, et al. Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 2011;96(3):F164-8. [PUBMED: 20659937]
3. Aydemir C, Oguz SS, Dizdar EA, Akar M, Sarikabadayi YU, Saygan S, et al. Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. Archives of Disease in Childhood 2011;96:F164-8. [PUBMED: 20659937]
4. Benjamin DK Jr, Hudak ML, Duara S, Randolph DA, Bidegain M, Mundakel GT, et al. Effect of Fluconazole Prophylaxis on Candidiasis and Mortality in Premature Infants. The Journal of the American Medical Association 2014;311(17):1742-9. [PUBMED: 24794367]
5. Cabrera C, Frank M, Carter D, Bhatia J. Fluconazole prophylaxis against systemic candidiasis after colonization: a randomized, double-blinded study. Journal of Perinatology 2002;22(7):604.
6. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. New England Journal of Medicine 2001;345(23):1660-6. [PUBMED: 11759644]
7. Kaufman D, Boyle R, Hazen KC, Robinson M, Donowitz LG. Effectiveness of fluconazole prophylaxis in the prevention of colonization and invasive infection in preterm infants. Pediatric Research 2001;50:309A.
8. Kaufman D, Boyle R, Robinson M, Grossman LB. Long-term safety of intravenous prophylactic fluconazole use in preterm infants less than 1000 grams. Pediatric Research 2003;53:2735.
9. Kaufman DA, Cuff AL, Wamstad JB, Boyle R, Gurka MJ, Grossman LB, et al. Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age. The Journal of Pediatrics 2011;158(5):759-65.e1. [PUBMED: 21168853]
10. Kaufman D, Boyle R, Hazen K, Patrie J, Robinson M, Grossman LB. Twice weekly fluconazole for prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight. The Journal of Pediatrics 2005;147(2):172-9. [PUBMED: 16126045]
11. Kicklighter SD, Springer SC, Cox T, Hulsey TC, Turner RB. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 2001;107(2):293-8. [PUBMED: 11158461]
12. Kicklighter SD, Springer SC, Phaller MA, Messer S, Cox T, Hulsey TC, et al. Fluconazole for prophylaxis against fungal rectal colonization in the very low birth weight infant. Pediatric Research 2000;47:342A.
13. Kim CS. Prevention of invasive candida infections in the neonatal intensive care unit. Korean Journal of Pediatric Infectious Diseases 2011;18(1):15-22.
14. Kim CS, Hong SA, Lee SL, Kim HS. Effect of fluconazole prophylaxis to control candida infection in high-risk preterm infants. Korean Journal of Perinatology 2010;21(4):378-87.
15. Kirpal H, Gathwala G, Chaudhary U, Sharma D. Prophylactic fluconazole in very low birth weight infants admitted to neonatal intensive care unit: randomized controlled trial. The Journal of Maternal-fetal & Neonatal Medicine 2015;Epub ahead of print:1-5. [PUBMED: 25708488]
16. Manzoni P, Stolfi I, Pugni L, Decembrino L, Magnani C, Vetrano G, et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. New England Journal of Medicine 2007;356(24):2483-95. [PUBMED: 17568029]
17. Manzoni P, Stolfi I, Pugni L, Decembrino L, Magnani C, Vetrano G, et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. New England Journal of Medicine 2007;356(24):2483-95. [PUBMED: 17568029]
18. Mersal A, Alzahrani I, Azzouz M, Alsubhi A, Alsawaigh H, Albshri N, et al. Oral nystatin versus intravenous fluconazole as neonatal antifungal prophylaxis: non-inferiority trial. Journal of Clinical Neonatology 2013;2(2):88-92. [PUBMED: 24049751]
19. Parikh TB, Nanavati RN, Patankar CV, Rao S, Bisure K, Udani RH, et al. Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants. Indian Pediatrics 2007;44(11):830-7. [PUBMED: 18057479]
20. Violaris K, Carbone T, Bateman D, Olawepo O, Doraiswamy B, LaCorte M. Comparison of fluconazole and nystatin oral suspensions for prophylaxis of systemic fungal infection in very low birthweight infants. American Journal of Perinatology 2010;27(1):73-8. [PUBMED: 19504425]
21. Violaris K, Doraiswamy B, Olawepo O, Gulrajani-LaCorte M. Fluconazole versus nystatin prophylaxis for fungal infection in very low birth weight (VLBW) infants. Pediatric Research 1998;44:254A.
22. Aghai ZH, Mudduluru M, Nakhla TA, Amendolia B, Longo D, Kemble N, et al. Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis. Journal of Perinatology 2006;26(9):550-5. [PUBMED: 16940972]
23. Al Qurashi MA, Alallah J, Salma EB, et al. Fluconazole prophylaxis is effective in reducing systemic fungal infection in VLBW infants. A single center four years retrospective study. Pediatric Research. 2008; Vol. 63.
24. Aziz M, Patel AL, Losavio J, Iyengar A, Berven M, Schloemer N, et al. Efficacy of fluconazole prophylaxis for prevention of invasive fungal infection in extremely low birth weight infants. The Pediatric Infectious Disease Journal 2010;29(4):352-6. [PUBMED: 19934791]
25. Bertini G, Perugi S, Dani C, Filippi L, Pratesi S, Rubaltelli FF. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants. The Journal of Pediatrics 2005;147(2):162-5. [PUBMED: 16126042]
26. Dutta S, Murki S, Varma S, Narang A, Chakrabarti A. Effects of cessation of a policy of neonatal fluconazole prophylaxis on fungal resurgence. Indian Pediatrics 2005;42(12):1226-30. [PUBMED: 16424560]
27. Healy CM, Baker CJ, Zaccaria E, Campbell JR. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. The Journal of Pediatrics 2005;147(2):166-71. [PUBMED: 16126043]
28. Healy CM, Campbell JR, Zaccaria E, Baker CJ. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics 2008;121(4):703-10. [PUBMED: 18381534]
29. Kim MR, Chavda C, Jha V, Badugu S, Chung NY, Jean-Baptiste D, et al. Prophylactic fluconazole therapy for very low birth weight infants colonised with Candida. Pediatric Research. 2008; Vol. 62.
30. Maede Y, Ibara S, Nagasaki H, Inoue T, Tokuhisa T, Torikai M, et al. Micafungin versus fluconazole for prophylaxis against fungal infections in premature infants. Pediatrics International 2013;55(6):727-30. [PUBMED: 23773357]
31. Manzoni P, Agrisio R, Mostert M, Leonessa M, Farina D, Latino MA, et al. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year retrospective cohort study. The Journal of Pediatrics 2006;117(1):e22-32. [PUBMED: 16326690]
32. Manzoni P, Leonessa M, Galletto P, Latino MA, Arisio R, Maule M, et al. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies. The Pediatric Infectious Disease Journal 2008;27(8):731-7. [PUBMED: 18600191]
33. McCrossan BA, McHenry E, O'Neill F, Ong G, Sweet DG. Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection. Archives of Disease in Childhood. Fetal and Neonatal Edition 2007;92(6):F454-8. [PUBMED: 17460023]
34. Rueda K, Moreno MT, Espinosa M, Saez-Llorens X. Impact of routine fluconazole prophylaxis for premature infants with birth weights of less than 1250 grams in a developing country. The Pediatric Infectious Disease Journal 2010;29(11):1050-2. [PUBMED: 20571460]
35. Uko S, Soghier LM, Vega M, Marsh J, Reinersman GT, Herring L, et al. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics 2006;117(4):1243-52. [PUBMED: 16585321]
36. Wadhawan R, Dumois J, Escoto D, et al. Near elimination of Candida sepsis after fluconazole prophylaxis in ELBW infants-experience from a tertiary level NICU. Pediatric Research. 2007; Vol. 62.
37. Weitkamp JH, Ozdas A, LaFleur B, Potts AL. Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure. Journal of Perinatology 2008;28(6):405-11. [PUBMED: 18185518]
38. Latif DA, Sultan MH, Mohamed HE. Efficacy of Prophylactic Fluconazole in Reducing Candidemia in High Risk NICU and PICU Patients. Life Science Journal 2012;9:817-24.
39. Adams-Chapman I, Bann CM, Das A, Goldberg RN, Stoll BJ, Walsh MC, et al. Neurodevelopmental outcome of extremely low birth weight infants with candida infection. The Journal of Pediatrics 2013;163(4):961-7. [PUBMED: 23726546]
40. Aliaga S, Clark RH, Laughon M, Walsh TJ, Hope WW, Benjamin DK, et al. Changes in the incidence of candidiasis in neonatal intensive care units. Pediatrics 2014;133(2):236-42. [PUBMED: 24446441]
41. Ascher SB, Smith PB, Watt K, Benjamin DK, Cohen-Wolkowiez M, Clark RH, et al. Antifungal therapy and outcomes in infants with invasive Candida infections. The Pediatric Infectious Disease Journal 2012;31(5):439-43. [PUBMED: 22189522]
42. Austin N, Darlow BA, McGuire W. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD003478.pub3]
43. Aydin B, Dilli D, Zenciroglu A, Uzunalic N, Okumus N, Aydin M. Lengthening of QT interval caused by fluconazole in a newborn. Journal of Clinical Toxicology 2012;2:132.
44. Barton M, O'Brien K, Robinson JL, Davies DH, Simpson K, Asztalos E, et al. Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls. BMC Infectious Diseases 2014;14:327. [PUBMED: 24924877]
45. Benjamin DK Jr, Poole C, Steibach WJ, Rowen JL, Walsh TJ. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics 2003;112(3 Pt 1):634-40. [PUBMED: 12949295]
46. Benjamin DK Jr, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006;117(1):84-92. [PUBMED: 16396864]
47. Brecht M, Clerihew L, McGuire W. Prevention and treatment of invasive fungal infection in very low birthweight infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 2009;94(1):F65-9. [PUBMED: 18838467]
48. Brion LP, Uko SE, Goldman DL. Risk of resistance associated with fluconazole prophylaxis: systematic review. Journal of Infection 2007;54(6):521-9. [PUBMED: 17239952]
49. Burwell LA, Kaufman D, Blakely J, Stoll BJ, Fridkin SK. Antifungal prophylaxis to prevent neonatal candidiasis: a survey of perinatal physician practices. Pediatrics 2006;118(4):e1019-26. [PUBMED: 16982807]
50. Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatric Clinics of North America 2013;60(2):367-89. [PUBMED: 23481106]
51. Clerihew L, Lamagni TL, Brocklehurst P, McGuire W. Invasive fungal infection in very low birthweight infants: national prospective surveillance study. Archives of Disease in Childhood. Fetal and Neonatal Edition 2006;91(3):F188-92. [PUBMED: 16332924]
52. Clerihew L, McGuire W. Antifungal prophylaxis for very low birthweight infants: UK national survey. Archives of Disease in Childhood. Fetal and Neonatal Edition 2008;93(3):F238-9. [PUBMED: 17768153]
53. Friedman S, Richardson SE, Jacobs SE, O'Brien K. Systemic candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmental outcome. The Pediatric Infectious Disease Journal 2000;19(6):499-504. [PUBMED: 10877162]
54. Gussenhoven MJ, Haak A, Peereboom-Wynia JD, van't Wout JW. Stevens-Johnson syndrome after fluconazole. Lancet 1991;338(8759):120. [PUBMED: 1676446]
55. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
56. Horbar JD, Badger GJ, Carpenter JH, Fanaroff AA, Kilpatrick S, LaCorte M, et al. Members of the Vermont Oxford Network. Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics 2002;110(1 Pt 1):143-51. [PUBMED: 12093960]
57. Hornik CP, Fort P, Clark RH, Watt K, Benjamin DK Jr, Smith PB, et al. Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Human Development 2012;88 Suppl 2:S69-74. [PUBMED: 22633519]
58. Huttova M, Hartmanova I, Kralinsky K, Filka J, Uher J, Kurak J, et al. Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis. The Pediatric Infectious Disease Journal 1998;17(11):1012-5. [PUBMED: 9849984]
59. Kaguelidou F, Pandolfini C, Manzoni P, Choonara I, Bonati M, Jacqz-Aigrain E. European survey on the use of prophylactic fluconazole in neonatal intensive care units. European Journal of Pediatrics 2012;171(3):439-45. [PUBMED: 21912893]
60. Karlowicz MG, Rowen JL, Barnes-Eley ML, Burke BL, Lawson ML, Bendel CM, et al. The role of birth weight and gestational age in distinguishing extremely low birth weight infants at high risk of developing candidemia from infants at low risk: a multicenter study. Pediatric Research 2002;51:301A.
61. Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clinical Microbiology Reviews 2004;17(3):638-80. [PUBMED: 15258097]
62. Kaufman DA, Gurka MJ, Hazen KC, Boyle R, Robinson M, Grossman LB. Patterns of fungal colonization in preterm infants weighing less than 1000 grams at birth. The Pediatric Infectious Disease Journal 2006;25(8):733-7. [PUBMED: 16874174]
63. Kaufman DA, Manzoni P. Strategies to prevent invasive candidal infection in extremely preterm infants. Clinics in Perinatology 2010;37(3):611-28. [PUBMED: 20813274]
64. Koklu E, Kalay S, Koklu S, Ariguloglu EA. Fluconazole administration leading to anaphylactic shock in a preterm newborn. Neonatal Network 2014;33(2):83-5. [PUBMED: 24589899]
65. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. The Pediatric Infectious Disease Journal 1998;17(6):504-8. [PUBMED: 9655543]
66. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics 2002;109(1):34-9. [PUBMED: 11773539]
67. Manzoni P, Farina D, Galletto P, Leonessa M, Priolo C, Arisio R, et al. Type and number of sites colonized by fungi and risk of progression to invasive fungal infection in preterm neonates in neonatal intensive care unit. Journal of Perinatal Medicine 2007;35(3):220-6. [PUBMED: 17378718]
68. Neely MN, Schreiber JR. Fluconazole prophylaxis in the very low birth weight infant: not ready for prime time. Pediatrics 2001;107(2):404-5. [PUBMED: 11158475]
69. O'Grady MJ, Dempsey EM. Antifungal prophylaxis for the prevention of neonatal candidiasis?. Acta Paediatrica 2008;97(4):430-3. [PUBMED: 18363952]
70. Oeser C, Lamagni T, Heath PT, Sharland M, Ladhani S. The epidemiology of neonatal and pediatric candidemia in England and Wales, 2000-2009. The Pediatric Infectious Disease Journal 2013;32(1):23-6. [PUBMED: 23241987]
71. Oeser C, Vergnano S, Naidoo R, Anthony M, Chang J, Chow P, et al. Neonatal invasive fungal infection in England 2004-2010. Clinical Microbiology and Infection 2014;20:936-41. [PUBMED: 24479862]
72. Pappu-Katikaneni LD, Rao KP, Banister E. Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants. Mycoses 1990;33(1):20-3. [PUBMED: 2342516]
73. Robinson JL, Davies HD, Barton M, O'Brien K, Simpson K, Asztalos E, et al. Characteristics and outcome of infants with candiduria in neonatal intensive care -a Paediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. BMC Infectious Diseases 2009;9:183. [PUBMED: 19930662]
74. Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin RT, Dawson J, et al. Risk factors for candidemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey study group. The Pediatric Infectious Disease Journal 2000;19(4):319-24. [PUBMED: 10783022]
75. Sarvikivi E, Lyytikäinen O, Soll DR, Pujol C, Pfaller MA, Richardson M, et al. Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. Journal of Clinical Microbiology 2005;43(6):2729-35. [PUBMED: 15956390]
76. Schelonka RL, Moser SA. Time to positive culture results in neonatal Candida septicemia. The Journal of Pediatrics 2003;142(5):564-5. [PUBMED: 12756391]
77. Shane AL, Stoll BJ. Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis. American Journal of Perinatology 2013;30(2):131-41. [PUBMED: 23297182]
78. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. The Journal of Pediatrics 1996;129(1):63-71. [PUBMED: 8757564]
79. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110(2 Pt 1):285-91. [PUBMED: 12165580]
80. Stoll BJ, Hansen N. Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Seminars in Perinatology 2003;27(4):293-301. [PUBMED: 14510320]
81. Vergnano S, Menson E, Kennea N, Embleton N, Russell AB, Watts T, et al. Neonatal infections in England: the NeonIN surveillance network. Archives of Disease in Childhood. Fetal and Neonatal Edition 2011;96(1):F9-14. [PUBMED: 20876594]
82. Wynn JL, Tan S, Gantz MG, Das A, Goldberg RN, Adams-Chapman I, et al. Outcomes following candiduria in extremely low birth weight infants. Clinical Infectious Diseases 2012;54(3):331-9. [PUBMED: 22144537]
83. Austin N, McGuire W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD003850.pub4]
84. Clerihew L, Austin N, McGuire W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database of Systematic Reviews 4, Issue 2007 10.1002/14651858.CD003850.pub3. [DOI: 10.1002/14651858.CD003850.pub3]
85. McGuire W, Clerihew L, Austin N. Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD003850.pub2]